MANNING MEREDITH (Chief Commercial Officer) received a stock award from SOLENO THERAPEUTICS INC
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 1/23/2025ACC: 0001415889-25-001936
Officer· Chief Commercial Officer
Since Apr 2024
+42.80K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
42.80K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+13.60K
Price / share
—
Trade value
—
% of position
34.0%
1/21/2025
40K→53.60K
Total
Net shares
+13.60K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/21/2025 | A · Award | +13.60K | — | — | 34.0% | 40K | 53.60K |
| Total | +13.60K | $0.00 | ||||||
Derivative Transactions1
Employee stock option (right to buy)
Direct
Converts to
Common Stock
29.20K shares
Shares
+29.20K
Strike price
49.17
Held after
29.20K
Exercisable
—
1/21/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Employee stock option (right to buy) Direct | Common Stock29.20K shares | 1/21/2025 | A · Award | +29.20K | 49.17 | — | 29.20K |